Managed care expects to broaden Crestor use

More good news for AstraZeneca's Crestor: Managed care pharmacy directors are saying they'll pay for the statin for healthy patients without high LDL cholesterol, but with elevated high sensitivity C-reactive protein, after the Jupiter trial found outcomes benefits from Crestor use in those patients. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.